1.Cureent therapy of lung cancer.
Korean Journal of Medicine 2002;62(6):600-607
No abstract available.
Lung Neoplasms*
;
Lung*
2.Levels of Serum Soluble Interleukin-2 Receptor in Patients with Chronic Myeloproliferative Disorders.
Korean Journal of Hematology 1997;32(2):248-255
BACKGROUND: A soluble form of interleukin-2 receptor (sIL-2R) is released from activated T cells. Serum sIL-2R levels are elevated in some hematological malignancies and could be used to assess disease activity and prognosis. MATERIAL AND METHODS: To define clinical usefulness and significance as a marker predicting disease progress in chronic myeloproliferative disorders, the serum levels of sIL-2R were measured in 40 cases of chronic myelogenous leukemia (CML; 25 chronic phase, 7 accelerating phase, 8 blastic phase), 3 cases of polycythemia vera (PV), 5 cases of essential thrombocythemia (ET) and 4 cases of idiopathic myelofibrosis (MF) and in 37 cases of healthy subjects using sandwich enzyme immunoassay. RESULTS: Serum sIL-2R levels in the patients of CML, PV, ET, and MF were higher compared with the normal healthy controls. In CML, serum sIL-2R levels in the patients of blastic and accelerating phases were significantly higher than those of chronic phase. In CML of chronic phase, serum sIL-2R levels at diagnosis were related to WBC count but not to other clinical and hematologic paramaters. The leukemic cells of one patient with lymphoblastic phase of CML expressed IL-2R (CD25). Among 4 patients of CML with sIL-2R levels above 2,000U/mL at diagnosis, transformation to blastic crisis was noted in 3 patients and 2 patients died within 1 year after diagnosis. But among 11 patients of CML with sIL-2R levels below 2,000U/mL at diagnosis, only 2 patients experienced blastic crisis and died within 1 year after diagnosis. CONCLUSION: This study indicated that serum sIL-2R levels were high in chronic myeloproliferative disorders, and that increasing levels of serum sIL-2R might be useful to predict disease progress. Further studies including more patients and longer follow-up may substantiate serum sIL-2R as a prognostic indicator in CML.
Diagnosis
;
Hematologic Neoplasms
;
Humans
;
Immunoenzyme Techniques
;
Interleukin-2*
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
Myeloproliferative Disorders*
;
Polycythemia Vera
;
Primary Myelofibrosis
;
Prognosis
;
T-Lymphocytes
;
Thrombocythemia, Essential
3.CMV Infection in AIDS Patients Depends on the Decrease of CD4+ T Cell Count eauth.
Young Keol CHO ; Yoo Kyum KIM ; Won IL OH ; Goon Jae CHO
Journal of the Korean Society of Virology 1998;28(4):359-368
Cytomegalovirus is the most common cause of life-threatening viral infection in HIV-infected patients. This study was done prospectively to investigate the incidence of CMV infection according to the decrease of CD4+ T cell count (CD4+) in Korean AIDS patients. Thirty-nine HIV-infected patients diagnosed before 1994 were followed for regular immunological monitoring. We have used urine shell vial method for the CMV detection from 1994 and have also checked clinical findings. Positive urine culture rate definitely depended on the CD4+ as follows; 45%, 22%, 17%, 11% and 0%, CD4+ >50, 50-100, 100-200, 200-500 and <500, respectively. Except culture positive 2 patients with CD4+ of 200~300/ul, all eight culture positive patients with CD4+ less than 200/ul showed CMV related diseases on or before urine culture. But, we could not get a positive culture for a late AIDS patient with vision loss. With ganciclovir therapy, all culture results were at least negative just after or on late of first 14 days-ganciclovir infusion-course. These data suggest that the incidence of CMV disease in Korean AIDS patients is very high, and early diagnosis and treatment for CMV diseases is required for the prevention of life threatening results.
Cell Count*
;
Cytomegalovirus
;
Early Diagnosis
;
Ganciclovir
;
Humans
;
Incidence
;
Monitoring, Immunologic
;
Prospective Studies
4.Hematoimmunological prognosis of AIDS patients in Korea.
Young Keol CHO ; Young Bong KIM ; Byung Sun CHOI ; Goon Jae CHO ; Young Ho WON ; Yung Oh SHIN
Korean Journal of Infectious Diseases 1992;24(3):161-169
No abstract available.
Humans
;
Korea*
;
Prognosis*
5.A Clinical Study and Prognostic Factors for Short-term Survival of Pneumocystis Carinii Pneumonia in Patients with AIDS.
Joo Seop CHUNG ; Goon Jae CHO ; Ihm Soo KWAK ; Ha Yeon RHA
Korean Journal of Medicine 1998;54(4):488-493
OBJECTIVES: Pneumocystis carinii pneumonia(PCP) is one of the most common life-threatening opportunistic infections in patients with acquired immunodeficiency syndrome(AIDS). This study reports the clinical charac teristics of PCP in the patients with AIDS and prognostic factors for short-term survival of them. METHODS: We investigated 43 patients of AIDS to evaluate the frequency of PCP in patients in AIDS by retrospective analysis, and classified the 17 patients with PCP into survivors and non-survivors to compare epide miology, clinical characteristics and laboratory findings. We also analyzed whether the these findings influenced the short-term survival in patients with PCP that was combined with AIDS. RESULTS: In this retrospective study of 43 patients of AIDS, the frequency of PCP in AIDS patients was relatively high as 17 patients(39%), of whom eight pa tients(47%) died of PCP. The epidemiologic findings such as age, route of human immunodeficiency virus(HIV) infection and co-existing disease were not significantly different between survivors and non-survivors. Coughing was the most common symptom and bilateral infiltrates of lung was the most common form in the chest X-ray examination. But these clinical features were similar in the both groups. Total lymphocyte count, CD4 cell count, serum albumin level and arterial oxygen tension were decreased and serum LDH was increased in patients with PCP that was the first episode in patients with AIDS. Lymphocyte and CD4 cell count were significantly lower in the non-survivor group (p=.002 and p=.03, respec tively). Survivors had higher serum albumin level and arterial oxygen tension than non-survivors (p=.02 and p=.04, respectively). And non-survivors were found to have higher serum LDH level than survivors (p=.02). CONCLUSION: Lymphocyte and CD4 cell counts, serum albumin and LDH, and arterial oxygen tension may be considered as the prognostic factors for short-term sur vival of patients with PCP that is combined with AIDS.
CD4 Lymphocyte Count
;
Cough
;
Humans
;
Lung
;
Lymphocyte Count
;
Lymphocytes
;
Opportunistic Infections
;
Oxygen
;
Pneumocystis carinii*
;
Pneumocystis*
;
Pneumonia, Pneumocystis*
;
Retrospective Studies
;
Serum Albumin
;
Survivors
;
Thorax
6.Clinical Usefulness of Flow Cytometric Measurement of P-glycoprotein, Glutathione S-Transferase pie and Topoisomerase II alpha Expression in Adult Acute Myelogenous Leukemia.
Jeong Nyeo LEE ; Eun Yup LEE ; Goon Jae CHO
Korean Journal of Hematology 1999;34(3):416-427
BACKGROUND: P-glycoprotein (PGP) is capable of expelling cytotoxic drugs from cytosol and the overexpression mediates drug resistance. However not all resistant leukemic cells express PGP. High expression of glutathione S-transferasepie (GSTpie) is related to clinical outcome following chemotherapy. Topoisomerase IIalpha (topo IIalpha) is a major target of anthracyclines for the treatment of leukemia. METHODS: To evaluate the relation of PGP, GSTpie and topo IIalpha expression to treatment outcome, PGP, GSTpie and topo IIalpha expression were analysed by flow cytometry using mono clonal antibodies (anti-JSB1, anti-GSTpie and anti-topo IIalpha) in 33 cases of de novo acute myelogenous leukemia. RESULTS: In patients with AML, the frequency of patients with high expression of PGP was 57.6% (19/33). The complete remission (CR) rate and mean survival duration were significantly different between patients with high expression and those with low expression of PGP (31.6 vs 92.9%, P=0.001; 83 vs 341 days, P=0.011). The frequency of patients with high expression of GST pie was 60.6% (20/33). The CR rate and mean survival duration were significantly different between patients with high expression and those with low expression of GSTpie (40.0 vs 84.6%, P=0.011; 115 vs 343 days, P=0.021). The frequency of patients with high expression of topo IIalpha is 78.8% (26/33) and treatment outcome was not related to topo IIalpha expression. In multivariate analysis with age, WBC count, PGP and GSTpie, PGP expression was an independent prognostic factor for treatment outcome. CONCLUSION: The flow cytometric measurement of PGP and GSTpie expression can be useful for the prediction of treament outcome following chemotherapy and PGP can be used as aprognostic factor in AML.
Adult*
;
Anthracyclines
;
Antibodies
;
Cytosol
;
DNA Topoisomerases, Type II*
;
Drug Resistance
;
Drug Resistance, Multiple
;
Drug Therapy
;
Flow Cytometry
;
Glutathione S-Transferase pi*
;
Glutathione Transferase*
;
Glutathione*
;
Humans
;
Leukemia
;
Leukemia, Myeloid, Acute*
;
Multivariate Analysis
;
P-Glycoprotein*
;
Treatment Outcome
7.Detection of resistance mutation to lamivudine in HIV-1 infected patients.
Young Keol CHO ; Heung Sup SUNG ; Hee Jung LEE ; Yoo Kyum KIM ; Hyun Sook CHI ; Goon Jae CHO ; Moon Won KANG
Journal of the Korean Society for Microbiology 2000;35(2):181-190
To investigate resistance to lamivudine (3TC), we examined the incidence of M184V in 20 HIV-1 patients treated with 3TC for 13.1 +/- 9 months. Fourteen of 20 patients had been exposed to zidovudine (ZDV) or didanosine (ddl) prior to 3TC therapy. Nested PCR targeting to reverse transcriptase (RT) and direct sequencing were performed for peripheral blood mononuclear cells sampled serially. There were resistance mutations to ZDV in at least 9 patients at baseline, although there was no resistance mutation to 3TC. We could detect M184V in 6 (30%) out of 20 patients. The incidence of M184V increased as the duration of therapy prolongs (13% in samples<12 months; 47% in samples gtoreq 12 months). The frequency of mutation M184V was higher in patients with previous mutation to ZDV than in patients with wild type. Resistance mutation was not detected in 7 patients. This study shows that resistance to 3TC tends to develop rapidly in patients with baseline mutations or two drugs combination therapy than in those treated simultaneously with triple drugs. This report is the first on resistance to 3TC in Korean AIDS patients.
Didanosine
;
HIV-1*
;
Humans
;
Incidence
;
Lamivudine*
;
Polymerase Chain Reaction
;
RNA-Directed DNA Polymerase
;
Zidovudine
8.Hypersensitivity to Mosquito Bites Associated with Natural Killer Cell-derived Large Granular Lymphocyte Lymphocytosis: A Case Report in Korea.
Joo Seop CHUNG ; Ho Jin SHIN ; Eun Yup LEE ; Goon Jae CHO
The Korean Journal of Internal Medicine 2003;18(1):50-52
Hypersensitivity to mosquito bites (HMB) is characterized by intense skin reactions at bite sites. The pathogenesis of HMB might be related to clonal lymphoproliferation of Epstein-Barr virus DNA-positive natural killer (NK) cells. We report the first case of HMB possibly associated with NK cell-derived large granular lymphocyte (NK-LGL) lymphocytosis in Korea.
Adult
;
Animals
;
Base Sequence
;
*Culicidae
;
Epstein-Barr Virus Infections/*complications/diagnosis
;
Humans
;
Hypersensitivity/*etiology/virology
;
Insect Bites and Stings/*complications/immunology
;
Killer Cells, Natural/*immunology/pathology
;
Korea
;
Lymphocytosis/*complications/pathology
;
Male
;
Molecular Sequence Data
;
Polymerase Chain Reaction
;
Prognosis
;
Risk Assessment
9.Outcome of Immunosuppressive Therapy with Helicobacter pylori Eradication Therapy in Patients with Chronic Idiopathic Thrombocytopenic Purpura.
Moo Kon SONG ; Joo Seop CHUNG ; Ho Jin SHIN ; Young Jin CHOI ; Goon Jae CHO
Journal of Korean Medical Science 2008;23(3):445-451
We initiated this study to investigate whether combining Helicobacter pylori eradication with immunosuppressive therapy provides an additional benefit to patients with idiopathic thrombocytopenic purpura (ITP) that has relapsed or has not responded to steroid and/or danazol therapy in patients who have H. pylori infection. Thirty- four patients with chronic ITP that had relapsed or failed to steroid and/or danazol therapy were assessed for H. pylori infection. Of the 21 confirmed cases, 12 patients were given H. pylori eradication therapy alone (EA), while 9 patients received eradication therapy combined with immunosuppressive therapy (EI). The response rate was not significantly different between patients in the EA and those in the EI group (41.7% in the EA group vs. 66.7% in the EI group, p=0.345). The median platelet count at 6 months after therapy was higher in the EI group patients (75X10(9)/L in the EI group patients vs. 18x109/L in the EA group patients, p=0.028). The median response duration was also longer in the EI group patients (9 months in the EI group patients vs. 3 months in the EA group patients, p=0.049). These results show that a significant benefit is gained by the use of H. pylori eradication combined with immunosuppressive therapy over the use of eradication therapy alone for patients with chronic ITP.
Adult
;
Aged
;
Anti-Bacterial Agents/*administration & dosage
;
Chronic Disease
;
Danazol/administration & dosage
;
Drug Therapy, Combination
;
Estrogen Antagonists/administration & dosage
;
Female
;
Helicobacter Infections/complications/*drug therapy
;
*Helicobacter pylori
;
Humans
;
Immunosuppressive Agents/*administration & dosage
;
Male
;
Middle Aged
;
Purpura, Thrombocytopenic, Idiopathic/complications/*drug therapy
;
Steroids/administration & dosage
;
Treatment Outcome
10.Prevalence and Specificity of Unexpected Antibody Using Antibody Screening Test Including Dia and Mia Cells.
Nak Hyun SUNG ; Tae Young JEON ; Eun Yup LEE ; Joo Seop CHUNG ; Goon Jae CHO ; Hyung Hoi KIM
The Korean Journal of Laboratory Medicine 2005;25(5):340-346
BACKGROUND: The purpose of this study was to examine the prevalence and distribution of unexpected antibodies detected in the Korean population with race-specific RBC panel cells. In spite of a relatively high prevalence of Dia and Mia antigen phenotype in the Korean and Southeast Asian population, there has been little documented research on the prevalence and clinical significance of anti-Dia and anti-Mia in Korea. METHODS: We analyzed the results of 17, 664 antibody screening tests performed during the recent 30-month period from March 2001 to September 2003. Antibodies were screened and identified by using LISS/Coombs gel card with DiaMed-ID system (DiaMed AG, Cressier, Morat, Switzerland) including Dia and Mia panel cells. RESULTS: The prevalence of unexpected antibodies was 1.2% (214/17, 664); antibodies detected most frequently were anti-Rh (74 patients), followed by anti-Lewis (21 patients) and anti-Dia (15 patients). Out of 6, 345 patients, anti-Mia was detected in three patients (0.047%). Anti-Dia and anti-Mia had the specificity of IgG. Anti-Dia was thought as an immune-mediated antibody, whereas anti-Mia was considered as a mixed type with immune and natural antibodies. CONCLUSIONS: This study shows that anti-Dia and anti-Mia antibodies are detected frequently in the Korean population; hence, it seems that Dia and Mia panel cells should be incorporated into antibody screening panels in Korea for safe transfusion.
Antibodies
;
Asian Continental Ancestry Group
;
Humans
;
Immunoglobulin G
;
Korea
;
Mass Screening*
;
Phenotype
;
Prevalence*
;
Sensitivity and Specificity*